"For the reporting year ending 31 December 2021, over 13,000 third party assessments were conducted through our Third Party Risk Management process. In this time period, there were no recorded cases of human rights violations including related to trafficking or slavery among the third parties surveyed. AstraZeneca’s Global Compliance function performs second line monitoring of Third Party Risk Assessments through sample review to assure that all forms of risk, including Employment

Principles risks, have been correctly identified and mitigated as appropriate. Our second line monitoring identified 5 engagements that required more in-depth review and risk mitigation by a contract manager." - pg. 7